Bassem A Bejjani

Summary

Affiliation: Signature Genomic Laboratories
Country: USA

Publications

  1. ncbi The use of microarray technology for cytogenetics
    Bassem A Bejjani
    Signature Genomic Laboratories, Spokane, WA, USA
    Methods Mol Biol 632:125-39. 2010
  2. ncbi Application of array-based comparative genomic hybridization to clinical diagnostics
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, 44 W 6th Ave, Suite 202, Spokane, WA 99204, USA
    J Mol Diagn 8:528-33. 2006
  3. ncbi Array-based comparative genomic hybridization in clinical diagnosis
    Bassem A Bejjani
    Signature Genomic Laboratories, 44 West 6th Avenue, Suite 202, Spokane, WA 99204, USA
    Expert Rev Mol Diagn 5:421-9. 2005
  4. ncbi Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more?
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, Spokane, WA 99204, USA
    Am J Med Genet A 134:259-67. 2005
  5. ncbi Clinical utility of contemporary molecular cytogenetics
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, Spokane, Washington 99202, USA
    Annu Rev Genomics Hum Genet 9:71-86. 2008
  6. ncbi Identification of a rare de novo three-way complex t(5;20;8)(q31;p11.2;p21) with microdeletions on 5q31.2, 5q31.3, and 8p23.2 in a patient with hearing loss and global developmental delay: case report
    Roland Haj
    Signature Genomic Laboratories, Spokane, WA, USA
    Mol Cytogenet 2:2. 2009
  7. ncbi Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases
    Lisa G Shaffer
    Signature Genomic Laboratories, LLC, Spokane, Washington, USA
    J Pediatr 149:98-102. 2006
  8. ncbi Comparative genomic hybridization by microarray for the detection of cytogenetic imbalance
    Malgorzata Jarmuz
    Health Research and Education Center, Washington State University, Spokane, WA, USA
    Methods Mol Med 128:23-31. 2006
  9. ncbi Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE
    Jill A Rosenfeld
    Signature Genomic Laboratories, Spokane, WA 99207, USA
    Hum Genet 127:421-40. 2010
  10. ncbi Detection of low-level mosaicism by array CGH in routine diagnostic specimens
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, Washington, USA
    Am J Med Genet A 140:2757-67. 2006

Collaborators

Detail Information

Publications48

  1. ncbi The use of microarray technology for cytogenetics
    Bassem A Bejjani
    Signature Genomic Laboratories, Spokane, WA, USA
    Methods Mol Biol 632:125-39. 2010
    ..Cytogeneticists are uniquely positioned to understand these mechanisms and assist genetic counselors and clinicians in their daily interactions with patients and families...
  2. ncbi Application of array-based comparative genomic hybridization to clinical diagnostics
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, 44 W 6th Ave, Suite 202, Spokane, WA 99204, USA
    J Mol Diagn 8:528-33. 2006
    ..This new platform is poised to revolutionize modern cytogenetic diagnostics and to provide clinicians with a powerful tool to use in their increasingly sophisticated diagnostic capabilities...
  3. ncbi Array-based comparative genomic hybridization in clinical diagnosis
    Bassem A Bejjani
    Signature Genomic Laboratories, 44 West 6th Avenue, Suite 202, Spokane, WA 99204, USA
    Expert Rev Mol Diagn 5:421-9. 2005
    ....
  4. ncbi Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more?
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, Spokane, WA 99204, USA
    Am J Med Genet A 134:259-67. 2005
    ....
  5. ncbi Clinical utility of contemporary molecular cytogenetics
    Bassem A Bejjani
    Signature Genomic Laboratories, LLC, Spokane, Washington 99202, USA
    Annu Rev Genomics Hum Genet 9:71-86. 2008
    ..Newer methodologies are being developed, which will likely lead to a new understanding of the genome and its relationship to health and disease...
  6. ncbi Identification of a rare de novo three-way complex t(5;20;8)(q31;p11.2;p21) with microdeletions on 5q31.2, 5q31.3, and 8p23.2 in a patient with hearing loss and global developmental delay: case report
    Roland Haj
    Signature Genomic Laboratories, Spokane, WA, USA
    Mol Cytogenet 2:2. 2009
    ..Although most CCRs appear balanced at the level of the light microscope, many demonstrate cryptic, submicroscopic imbalances at the translocation breakpoints...
  7. ncbi Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases
    Lisa G Shaffer
    Signature Genomic Laboratories, LLC, Spokane, Washington, USA
    J Pediatr 149:98-102. 2006
    ..To assess the yield of array-based comparative genomic hybridization...
  8. ncbi Comparative genomic hybridization by microarray for the detection of cytogenetic imbalance
    Malgorzata Jarmuz
    Health Research and Education Center, Washington State University, Spokane, WA, USA
    Methods Mol Med 128:23-31. 2006
    ..Properly constructed, microarrays have the potential to be a valuable tool for the detection of chromosomal abnormalities in cancer and genetic disease...
  9. ncbi Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE
    Jill A Rosenfeld
    Signature Genomic Laboratories, Spokane, WA 99207, USA
    Hum Genet 127:421-40. 2010
    ..A search for significant aCGH findings in individuals referred for testing for HPE revealed a novel association of a duplication involving GSK3B at 3q13.33 with HPE or a microform, seen in two unrelated individuals...
  10. ncbi Detection of low-level mosaicism by array CGH in routine diagnostic specimens
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, Washington, USA
    Am J Med Genet A 140:2757-67. 2006
    ..Thus, array CGH, which is based on genomic DNA extracted directly from uncultured peripheral blood, may be more likely to detect low-level mosaicism for unbalanced chromosome abnormalities than traditional cytogenetic techniques...
  11. ncbi Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate
    Trilochan Sahoo
    Signature Genomics, Spokane, Washington, USA
    Am J Med Genet A 155:1646-53. 2011
    ..Lack of significant phenotypic components in family members of Patient 1 suggests variable expressivity for the phenotype...
  12. ncbi Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray
    Justine Coppinger
    Signature Genomic Laboratories, Spokane, WA, USA
    Prenat Diagn 29:1156-66. 2009
    ..To determine the detection rates of whole-genome microarray technology compared to targeted microarray analysis for chromosome abnormalities in prenatal samples submitted for diagnostic testing...
  13. ncbi aCGH detects partial tetrasomy of 12p in blood from Pallister-Killian syndrome cases without invasive skin biopsy
    Aaron Theisen
    Signature Genomic Laboratories, Spokane, Washington 99207, USA
    Am J Med Genet A 149:914-8. 2009
    ....
  14. ncbi The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future
    Lisa G Shaffer
    Signature Genomic Laboratories, LLC, 120 N Pine Street, Ste 242C, Spokane, WA 99202, USA
    Am J Med Genet C Semin Med Genet 145:335-45. 2007
    ..c) 2007 Wiley-Liss, Inc...
  15. ncbi Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems
    Trilochan Sahoo
    Signature Genomic Laboratories, 2820 N Astor St, Spokane, WA 99207, USA
    Genet Med 13:868-80. 2011
    ....
  16. ncbi High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44
    Blake C Ballif
    Signature Genomic Laboratories, Spokane, WA 99207, USA
    Hum Genet 131:145-56. 2012
    ....
  17. ncbi The clinical utility of enhanced subtelomeric coverage in array CGH
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, Washington 99202, USA
    Am J Med Genet A 143:1850-7. 2007
    ..Microarrays designed to investigate regions known to be involved in chromosome abnormalities will enhance the detection of cytogenetic abnormalities at unprecedented resolution and frequency...
  18. ncbi Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens
    Lisa G Shaffer
    Signature Genomic Laboratories, Spokane, WA 99202, USA
    Prenat Diagn 28:789-95. 2008
    ..To compare the detection rate by microarray analysis for chromosome abnormalities in a prenatal population to that of a neonatal population referred for diagnostic testing...
  19. ncbi Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations
    Jill A Rosenfeld
    Signature Genomic Laboratories, 2820 N AstorStreet, Spokane, WA 99207, USA
    Genet Med 11:797-805. 2009
    ..Previous reports have suggested that the Pitt-Hopkins syndrome phenotype is independent of mutation or deletion type...
  20. ncbi Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities
    Blake C Ballif
    Signature Genomic Laboratories, Spokane, WA 99207, USA
    Am J Hum Genet 86:454-61. 2010
    ....
  21. ncbi The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome
    Lisa G Shaffer
    Health Research and Education Center, Washington State University, Spokane, Washington, USA
    Genet Med 9:607-16. 2007
    ..We report as an illustrative example the characterization of a novel microdeletion syndrome of 1q41q42...
  22. ncbi Deletions and duplications of developmental pathway genes in 5q31 contribute to abnormal phenotypes
    Jill A Rosenfeld
    Signature Genomic Laboratories, Spokane, Washington, USA
    Am J Med Genet A 155:1906-16. 2011
    ..Although development is likely affected by increased dosage of the genes in the region, the developmental disruption appears less severe than that seen with deletion...
  23. ncbi Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2
    Blake C Ballif
    Signature Genomic Laboratories, Spokane, Washington 99202, USA
    Nat Genet 39:1071-3. 2007
    ..2-p12.2 constitute a previously undescribed syndrome...
  24. ncbi Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH
    Sara Anne Adams
    Signature Genomic Laboratories, LLC, Spokane, Washington, USA
    Genet Med 11:314-22. 2009
    ..In these cases, diagnosis before the manifestation of the patient's full phenotype dramatically impacts genetic counseling, clinical management, and eventual prognosis and survivability...
  25. ncbi Detecting sex chromosome anomalies and common triploidies in products of conception by array-based comparative genomic hybridization
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, WA 99204, USA
    Prenat Diagn 26:333-9. 2006
    ..However, array CGH, like all CGH procedures, has heretofore been deemed unable to detect ploidy, a major cause of fetal demise and spontaneous miscarriage...
  26. ncbi Development of a high-density pericentromeric region BAC clone set for the detection and characterization of small supernumerary marker chromosomes by array CGH
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, Washington 99210 1495, USA
    Genet Med 9:150-62. 2007
    ....
  27. ncbi Localization of a gene for keratoconus to a 5.6-Mb interval on 13q32
    Marzena Gajecka
    Basic Medical Sciences Program, Washington, Wyoming, Alaska, Montana, and Idaho, Washington State University, Spokane, Washington 99210 1495, USA
    Invest Ophthalmol Vis Sci 50:1531-9. 2009
    ..There is also evidence that VSX1 and SOD1 may be involved in the etiology of KTCN. The purpose of this study was to verify the available data and to identify a new keratoconus susceptibility locus...
  28. ncbi Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region
    Justine Coppinger
    Signature Genomic Laboratories, LLC, Spokane, WA 99207, USA
    Hum Mol Genet 18:1377-83. 2009
    ..The variable phenotypes and preponderance of familial cases obfuscate the clinical relevance of the molecular data and emphasize the need for careful parental assessments and clinical correlations...
  29. ncbi Of mice and men: tyrosinase modification of congenital glaucoma in mice but not in humans
    Carla Bidinost
    Health Research and Education Center, Washington State University Spokane, Spokane, Washington 99210 1495, USA
    Invest Ophthalmol Vis Sci 47:1486-90. 2006
    ..In the current study, tyrosinase (TYR) was investigated in human PCG...
  30. ncbi Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders
    Jill A Rosenfeld
    Signature Genomic Laboratories, Spokane, Washington 99207, USA
    Genet Med 12:694-702. 2010
    ..Microarray-based comparative genomic hybridization and other molecular cytogenetic techniques are discovering an increasing number of copy number variations in individuals with autism spectrum disorder...
  31. ncbi Development of new postnatal diagnostic methods for chromosome disorders
    Lisa G Shaffer
    Signature Genomic Laboratories, Spokane, WA 99207, USA
    Semin Fetal Neonatal Med 16:114-8. 2011
    ....
  32. ncbi Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication
    Blake C Ballif
    Signature Genomic Laboratories, LLC, Spokane, WA, USA
    Mol Cytogenet 1:8. 2008
    ..6 Mb common-sized deletion. Given the molecular mechanism causing the deletion, the reciprocal duplication is anticipated to occur with equal frequency, although only one family with this duplication has been reported...
  33. ncbi Design, development, validation, and use of synthetic nucleic acid controls for diagnostic purposes and application to cystic fibrosis testing
    Todd M Christensen
    Molecular Diagnostics Laboratory, Sacred Heart Medical Center Spokane, Spokane, WA 99204, USA
    J Mol Diagn 9:315-9. 2007
    ..It has not escaped our notice that the design of these molecules makes possible the production of similar controls for virtually any mutation or sequence of interest...
  34. ncbi Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH
    Nicholas J Neill
    Signature Genomic Laboratories, Spokane, WA, USA
    Mol Cytogenet 3:11. 2010
    ....
  35. ncbi Effects of ozone exposure during microarray posthybridization washes and scanning
    Steve Byerly
    Signature Genomic Laboratories, 2820 N Astor St, Spokane, WA 99207, USA
    J Mol Diagn 11:590-7. 2009
    ..We also found that washed microarrays produce the best results when immediately scanned; however, if a low-ozone environment is maintained, there will be little compromise in the data collected...
  36. ncbi A cytogeneticist's perspective on genomic microarrays
    Lisa G Shaffer
    Health Research and Education Center, Washington State University Spokane, Sacred Heart Medical Center, and Signature Genomic Laboratories, Spokane, Washington, USA
    Hum Reprod Update 10:221-6. 2004
    ..We anticipate that array CGH will be employed in the clinical cytogenetics laboratory in the near future and will lead to the identification of the chromosomal basis of new syndromes and existing genetic conditions...
  37. ncbi Heterozygous and homozygous mutations in PITX3 in a large Lebanese family with posterior polar cataracts and neurodevelopmental abnormalities
    Carla Bidinost
    Health Research and Education Center, Washington State University Spokane, Spokane, Washington, USA
    Invest Ophthalmol Vis Sci 47:1274-80. 2006
    ..Also studied were two siblings who were homozygous for the PITX3 mutation who had microphthalmia and significant neurologic impairment...
  38. ncbi Partial deletions of the long arm of chromosome 13 associated with holoprosencephaly and the Dandy-Walker malformation
    W Michael McCormack
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Med Genet 112:384-9. 2002
    ..Therefore, careful high-resolution cytogenetic analysis (550 band level or greater) of 13q22-q33 may be considered in these patients. Furthermore, future molecular studies of this region may reveal candidate gene loci for the DWM...
  39. ncbi Partial deletions of the long arm of chromosome 13 associated with holoprosencephaly and the Dandy-Walker malformation
    W Michael McCormack
    Department of Molecular and Human Genetics, Baylor College of Medicine, Room S434, One Baylor Plaza, Houston, TX 77030, USA
    Am J Med Genet A 118:384-9. 2003
    ..Therefore, careful high-resolution cytogenetic analysis (550 band level or greater) of 13q22-q33 may be considered in these patients. Furthermore, future molecular studies of this region may reveal candidate gene loci for the DWM...
  40. ncbi Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions
    Wei Yu
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
    Hum Mol Genet 12:2145-52. 2003
    ..We anticipate that array CGH will change the diagnostic approach to many congenital and acquired genetic diseases such as mental retardation, birth defects and cancer...
  41. ncbi Williams syndrome in a preterm infant with phenotype of Alagille syndrome
    Prakesh S Shah
    Department of Pediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Am J Med Genet A 146:2407-11. 2008
    ..This case illustrates the importance of microarray analysis in diagnosing genetic conditions, especially in preterm babies whose facial and other clinical manifestations have not fully developed...
  42. ncbi Coarctation of the aorta and mild to moderate developmental delay in a child with a de novo deletion of chromosome 15(q21.1q22.2)
    Seema R Lalani
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
    BMC Med Genet 7:8. 2006
    ..Congenital heart disease has been described in three individuals with interstitial deletion involving this region of chromosome 15...
  43. ncbi Craniofacial anomalies, deafness, brachydactyly, short stature, and moderate mental retardation due to a cryptic 6p;11q translocation
    Andre Megarbane
    Unite de Genetique Medicale, Faculte de Medecine, Université Saint Joseph, Beirut, Lebanon, France
    Am J Med Genet 108:69-74. 2002
    ..The phenotype of the twins is most likely related to this cryptic chromosomal rearrangement. The fact that the phenotype in this family partially overlaps with some previously reported phenotypes is discussed...
  44. ncbi Identification of a novel polymorphism--the duplication of the NPHP1 (nephronophthisis 1) gene
    Hagit Baris
    Division of Genetics, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts 02115, USA
    Am J Med Genet A 140:1876-9. 2006
  45. ncbi Developing a sustainable process to provide quality control materials for genetic testing
    Bin Chen
    Quality Control Materials for Genetic Testing Group, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Genet Med 7:534-49. 2005
    ..A Genetic Testing Quality Control Materials Program has therefore been established by CDC in March 2005 to serve these needs...
  46. ncbi Identification of uniparental disomy in phenotypically abnormal carriers of isochromosomes or Robertsonian translocations
    Sue Ann Berend
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Med Genet 111:362-5. 2002
    ..Our results and the large number of case reports in the literature suggest that patients with abnormal phenotypes and acrocentric rearrangements of chromosomes 14 or 15 should be tested for UPD...
  47. ncbi Refinement of the genomic structure of STX1A and mutation analysis in nondeletion Williams syndrome patients
    Yuan-qing Wu
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Med Genet 109:121-4. 2002
    ..Although the regulatory elements that control STX1A transcription were not examined, these results do not support a role for STX1A in the WS phenotype...
  48. ncbi Expanding the phenotype of alveolar capillary dysplasia (ACD)
    Partha Sen
    Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
    J Pediatr 145:646-51. 2004
    ....